# Hepatocellular Cancer (HCC) Screening in Zhongshan City

> **NCT02501980** · — · UNKNOWN · sponsor: **Zhongshan People's Hospital, Guangdong, China** · enrollment: 20000 (actual)

## Conditions studied

- Liver Neoplasms

## Interventions

- **BIOLOGICAL:** Biomarker testing and Ultrasonography

## Key facts

- **NCT ID:** NCT02501980
- **Lead sponsor:** Zhongshan People's Hospital, Guangdong, China
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-01
- **Primary completion:** 2024-01
- **Final completion:** 2024-12
- **Target enrollment:** 20000 (ACTUAL)
- **Last updated:** 2023-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02501980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02501980, "Hepatocellular Cancer (HCC) Screening in Zhongshan City". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02501980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*